These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16879061)

  • 1. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium.
    Bakker AJ; Boerma EC; Keidel H; Kingma P; van der Voort PH
    Clin Chem Lab Med; 2006; 44(8):962-6. PubMed ID: 16879061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury.
    Liu DL; Huang LF; Ma WL; Ding Q; Han Y; Zheng Y; Li WX
    Chin Med J (Engl); 2016 Jul; 129(14):1682-7. PubMed ID: 27411455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration.
    Hetzel GR; Taskaya G; Sucker C; Hennersdorf M; Grabensee B; Schmitz M
    Am J Kidney Dis; 2006 Nov; 48(5):806-11. PubMed ID: 17060000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrate anticoagulation for continuous venovenous hemofiltration.
    Oudemans-van Straaten HM; Bosman RJ; Koopmans M; van der Voort PH; Wester JP; van der Spoel JI; Dijksman LM; Zandstra DF
    Crit Care Med; 2009 Feb; 37(2):545-52. PubMed ID: 19114912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A; Daul AE; Beiderlinden M; Schäfers RF; Heemann U; Kribben A; Peters J; Philipp T; Wenzel RR
    Clin Nephrol; 2003 Feb; 59(2):106-14. PubMed ID: 12608553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L; Nurmohamed SA; Bosch FH; Purmer IM; den Boer SS; Kleppe CG; Vervloet MG; Beishuizen A; Girbes AR; Ter Wee PM; Groeneveld AB;
    Crit Care; 2014 Aug; 18(4):472. PubMed ID: 25128022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.
    Tan JN; Haroon SWP; Mukhopadhyay A; Lau T; Murali TM; Phua J; Tan ZY; Lee N; Chua HR
    J Intensive Care Med; 2019 May; 34(5):418-425. PubMed ID: 28372501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration.
    Fealy N; Baldwin I; Johnstone M; Egi M; Bellomo R
    Int J Artif Organs; 2007 Apr; 30(4):301-7. PubMed ID: 17520566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commercial low-citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting.
    Naka T; Egi M; Bellomo R; Cole L; French C; Botha J; Wan L; Fealy N; Baldwin I
    Anaesth Intensive Care; 2005 Oct; 33(5):601-8. PubMed ID: 16235478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational study on the effects of nadroparin-based and citrate-based continuous venovenous hemofiltration on calcium metabolism.
    van der Voort PH; Postma SR; Kingma WP; Boerma EC; de Heide LJ; Bakker AJ
    Blood Purif; 2007; 25(3):267-73. PubMed ID: 17446700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous venovenous haemofiltration using a citrate buffered substitution fluid.
    Schmitz M; Taskaya G; Plum J; Hennersdorf M; Sucker C; Grabensee B; Hetzel GR
    Anaesth Intensive Care; 2007 Aug; 35(4):529-35. PubMed ID: 18020071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study.
    Aman J; Nurmohamed SA; Vervloet MG; Groeneveld AB
    J Crit Care; 2010 Mar; 25(1):120-7. PubMed ID: 19427760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration.
    Egi M; Naka T; Bellomo R; Cole L; French C; Trethewy C; Wan L; Langenberg CC; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Dec; 28(12):1211-8. PubMed ID: 16404696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance.
    Naka T; Egi M; Bellomo R; Cole L; French C; Wan L; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Mar; 28(3):222-8. PubMed ID: 15818544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations.
    Munjal S; Ejaz AA
    Nephrology (Carlton); 2006 Oct; 11(5):405-9. PubMed ID: 17014553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R; Niles JL
    Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.
    Hetzel GR; Schmitz M; Wissing H; Ries W; Schott G; Heering PJ; Isgro F; Kribben A; Himmele R; Grabensee B; Rump LC
    Nephrol Dial Transplant; 2011 Jan; 26(1):232-9. PubMed ID: 20876598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study.
    Schultheiß C; Saugel B; Phillip V; Thies P; Noe S; Mayr U; Haller B; Einwächter H; Schmid RM; Huber W
    Crit Care; 2012 Aug; 16(4):R162. PubMed ID: 22913794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.